Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milburn

Showing results (801-810 of 850) with videos related to

Pageof 85
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 25, 2026
Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC)Phillip J Hopley, Ryan Peysner, Annabelle Boughey, et al.
Cancer Research|December 4, 2015
SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the CytoplasmKevin J Hamblett, Allison P Jacob, Jesse L Gurgel, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Chan Gao, Megan Raymond, et al.
Diabetes|July 26, 2013
Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approachCristina Menni, Eric Fauman, Idil Erte, et al.
Open Forum Infectious Diseases|October 22, 2024
Computed Tomography of the Head Before Lumbar Puncture in Adults With Suspected Meningitis in High-HIV Prevalence SettingsJames Milburn, Christopher G Williams, Kwana Lechiile, et al.
The European Respiratory Journal|June 10, 2010
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statementI Solovic, M Sester, J J Gomez-Reino, et al.
The Lancet. Infectious Diseases|September 4, 2018
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort studyIbrahim Abubakar, Francis Drobniewski, Jo Southern, et al.
Plos Pathogens|July 16, 2013
Ethnic variation in inflammatory profile in tuberculosisAnna K Coussens, Robert J Wilkinson, Vladyslav Nikolayevskyy, et al.
Pageof 85

Showing results (801-810 of 850) with videos related to

Sort By:
Pageof 85
European Journal of Cancer (Oxford, England : 1990)|February 25, 2026
Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC)Phillip J Hopley, Ryan Peysner, Annabelle Boughey, et al.
Cancer Research|December 4, 2015
SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the CytoplasmKevin J Hamblett, Allison P Jacob, Jesse L Gurgel, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid TumorsRui Wang, Chan Gao, Megan Raymond, et al.
Diabetes|July 26, 2013
Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approachCristina Menni, Eric Fauman, Idil Erte, et al.
Open Forum Infectious Diseases|October 22, 2024
Computed Tomography of the Head Before Lumbar Puncture in Adults With Suspected Meningitis in High-HIV Prevalence SettingsJames Milburn, Christopher G Williams, Kwana Lechiile, et al.
The European Respiratory Journal|June 10, 2010
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statementI Solovic, M Sester, J J Gomez-Reino, et al.
The Lancet. Infectious Diseases|September 4, 2018
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort studyIbrahim Abubakar, Francis Drobniewski, Jo Southern, et al.
Plos Pathogens|July 16, 2013
Ethnic variation in inflammatory profile in tuberculosisAnna K Coussens, Robert J Wilkinson, Vladyslav Nikolayevskyy, et al.
Pageof 85